Skip to main content
. 2019 Mar 16;7(2):115–128. doi: 10.1016/j.esxm.2019.01.001

Table 1.

Baseline characteristics for all studies included in the quantitative synthesis

Type of graft Lead author Study characteristics
Limitations
Patient demographics
Year Number of patients Follow-up, mo, (SD; range) Country Study years Methodological Noted by authors Previous operation Age, y, mean (SD; range) Onset duration, mo (SD; range) Degree of curvature (SD; range) Complex deformity, % (n/N) Plaque size, cm
Xenograft Sayedahmed19 2017 43 33 (NM; 10–59) Germany 2007–2015 Nonrandomized No standardized questionnaire for evaluation; no predictive factors for postoperative outcome NM 57.4 (NM; 39–82) sdf 4 73.8 (NM; 60–90) NM 2.1 (1-4)
Cosentino20 2016 44 19.2 (NM; 11–48) Spain 2009–2013 No IIEF, retrospective, no satisfaction measure, no penile length measurement NM 56.1 (NM; 49–64) 24 (MM; 9-48) >60 in 40 patients NM NM
Knoll21 2007 162 38 (NM; 6–96) US 1998–2006 No IIEF, retrospective, no satisfaction measurement NM 52 (NM; 33–69) 16 (NM; 12–30) 70 (NM; 60–100) 0 1.5 × 4.0–3.0 × 6.0
Sansalone22 2011 157 20 (NM; 1224) Italy/Serbia 2004–2008 Retrospective, no penile length measurement Only 89 patients completed the IIEF. NM 55 (±11; 29–70) sdf 6–12 NM (NM; NM) NM NM
Allograft Sampaio23 2002 40 NM (NM; 16) Portugal 1989–1999 No IIEF, retrospective, no satisfaction measurement NM 56 (NM; 43–69) NM (NM; 24–96) NM (NM; NM) NM 1–7 × 2–2.5
Autograft Kadioglu24 2018 144 51.1 (±39.6; NM) Turkey 1997–2016 No IIEF, retrospective, no satisfaction measurement, no penile length measurement NM 54.1 (±9.2; NM) 28.2 (±17.3; NM) 58.4 (±18.9; NM) 32.5 (37/114) NM
Kalsi25 2005 113 12 (NM; 8–70) UK 1996–2004 No IIEF, retrospective, no satisfaction measurement 6/113 45 (NM; 17–71) 24 (NM; NM) 64.5 (NM; 20–180) 15.9 (18/113)§ NM
Montorsi26 2000 50 32 (NM; 15–54) Italy 1995–1998 No IIEF, retrospective NM 44 (NM; 28–62) sdf 6 60 (±4; NM) NM NM
Akkus27 2001 58 NM Turkey 1994–1999 No IIEF, retrospective, no satisfaction measurement 0/58 50 (NM; 39–63) NM (NM; 12–60) NM (NM; NM) NM NM
El-Sakka13 1998 112 NM US 1995–1997 No IIEF, retrospective NM 52 (22–73) sdf 3 <90 in 82 patients, >90 in 30 patients 10.7 (12/113) NM
Multiple Flores15 2011 56 NM US 2002–2004 Retrospective, no satisfaction measurement, no penile length measurement No recording of pertinent preoperative characteristics, such as mean preoperative curvature, hemodynamics, and erectile function NM 57 (±22; NM) 22 (±9; NM) 52 (± 23; NM) 10.7 (6/56) 4.7 ± 1.2 cm2
Chung28 2011 86 98 (NM; 61–120) Canada 1995–2005 Retrospective Small sample size, patients lost to follow-up, nonrandomized graft material selection, surgery performed across different timelines 0/86 54.6 (NM; 34–73) 29.1 (NM; 8–60) 71.7 (NM; 30–160) NM NM

NM = not mentioned; SD = standard deviation; sdf = stable disease for.

46 contacted for follow-up.

4 had pure hourglass; 4 had concomitant dorsal deformity.

Median.

§

Waist deformity.